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Abstract
Staphylococcus aureus is highly prevalent among patients with atopic dermatitis (AD), and this pathogen may trigger and
aggravate AD lesions. The aim of this study was to determine the prevalence of S. aureus in the nares of pediatric subjects and
verify the phenotypic and molecular characteristics of the isolates in pediatric patients with AD. Isolates were tested for
antimicrobial susceptibility, SCCmec typing, and Panton-Valentine Leukocidin (PVL) genes. Lineages were determined by
pulsed-field gel electrophoresis and multilocus sequence typing (MLST). AD severity was assessed with the Scoring Atopic
Dermatitis (SCORAD) index. Among 106 patients, 90 (85%) presented S. aureus isolates in their nares, and 8 also presented
the pathogen in their skin infections. Two patients had two positive lesions, making a total of 10 S. aureus isolates from skin
infections. Methicillin-resistant S. aureus (MRSA) was detected in 24 (26.6%) patients, and PVL genes were identified in 21
(23.3%), including 6 (75%) of the 8 patients with skin lesions but mainly in patients with severe and moderate SCORAD values
(P=0.0095). All 24 MRSA isolates were susceptible to trimethoprim/sulfamethoxazole, while 8 isolates had a minimum
inhibitory concentration (MIC) to mupirocin .1024 mg/mL. High lineage diversity was found among the isolates including
USA1100/ST30, USA400/ST1, USA800/ST5, ST83, ST188, ST718, ST1635, and ST2791. There was a high prevalence of
MRSA and PVL genes among the isolates recovered in this study. PVL genes were found mostly among patients with severe
and moderate SCORAD values. These findings can help clinicians improve the therapies and strategies for the management of
pediatric patients with AD.
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Introduction
Atopic dermatitis (AD) is a chronic inflammatory skin
disease (1) that affects 10-20% of children worldwide (2).
Several indexes have been proposed to assess AD severity;
however, SCORAD (scoring atopic dermatitis) is the most
widely used index (3). It adds a point for each symptom such
as extension of eczema, dryness, pruritus, sleep disturbance,
etc. Patients who score.25, 25-50, or.50 are considered to
have mild, moderate, and severe AD, respectively.
Genetic predisposition, skin barrier defects, and environ-
mental exposure are considered to be associated with the
development of AD (4). Skin colonization by S. aureus may
also contribute to the onset and/or aggravation of lesions (5)
because staphylococcal toxins such as Panton-Valentine
Leukocidin (PVL) and superantigens can aggravate the
eczema (6). The prevalence of S. aureus in AD patients is
up to 80% in nasal colonization (7-9) and can vary from 75%
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to 100% in skin lesions (8-11), while for methicillin-resistant
S. aureus (MRSA), the prevalence ranges from 0.5% to 16%
(7-10,12,13).
The resistance to methicillin in S. aureus is encoded in
a Staphylococcal chromosome cassette mec (SCCmec),
of which there are 11 types. Among AD patients, MRSA
isolates usually carry mec cassettes commonly found in
healthy individuals from the community, such as types IV
and V (11). The genetic profile of most MRSA recovered
from AD children belongs to well-established community
lineages of different geographical regions such as ST188 in
Korea (11).
Although some studies have reported S. aureus
prevalence in AD patients, as well as the detection of
the bacterial virulence factors and their relation with
clonality (7,9,11), this has not yet been analyzed
in Brazil. Therefore, this study aimed to verify the
prevalence of S. aureus colonization, including MRSA,
in pediatric outpatients with AD and characterize the
SCCmec types, PVL genes, and clonality of isolates from
nares and AD skin lesions. In addition, we correlated the
presence of PVL genes with disease severity and isolate
characteristics.
Material and Methods
Setting and study populations
A cross-sectional study was conducted between
September 2011 and September 2012 at the Univer-
sidade Federal do Rio de Janeiro hospital pediatric der-
matology outpatient clinic, which provides assistance to
about 130 AD pediatric patients. The target population of
the study included patients diagnosed with AD of both
genders who were 16 years old or less. The population
was predominantly low income. The study was approved
by the Ethics Committee of Instituto de Pediatria e Pueri-
cultura Martaga˜o Gesteira, Universidade Federal do Rio
de Janeiro (#51/11).
Collection and bacterial isolates
Swabs from the anterior nares and infected skin lesions
were obtained from 106 patients. All infected skin sites of
skin with infection were analyzed. Specimens were cultured
on mannitol salt agar (Oxoid, UK) and characterized with
standardized tests (14). The following controls were used:S.
aureus strains ATCC 25923 and ATCC 29213 (for suscep-
tibility tests), Mu50 (SCCmec type II) (15), and the clinical
isolates described previously (SCCmec types II, III and IV;
PVL genes positive) (16).
Antimicrobial susceptibility tests
All isolates were submitted to diffusion testing (17) and
minimum inhibitory concentrations (MICs) for oxacillin and
vancomycin by microdilution broth (18). The MIC test for
mupirocin was performed by the E-test1 (BioMe´rieux,
France) in all mupirocin-resistant isolates.
Characterization of SCCmec type and detection of
PVL-encoding genes
Bacterial DNA was extracted (19), and all S. aureus
isolates were submitted to polymerase chain reaction (PCR)
for PVL genes (20). SCCmec typing was performed on all
MRSA isolates (21).
PFGE, RM test, and MLST
Eighteen S. aureus isolates from 8 patients who pre-
sented at least two clinical sites positive for the pathogen
were evaluated for genotypes by pulsed-field electro-
phoresis (PFGE) (22). This technique is based on DNA
fragmentation followed by electrophoresis. Each isolate
submitted to PFGE shows a band pattern. The isolates were
grouped in clones according to band patterns similarities
(23), and the clonality was obtained by comparisons with
previously published images (24). A restriction-modification
(RM) test was carried out to determine the bacterial clonal
complexes (25). Isolates that were not included in a clonal
complex by the RM test were submitted to the multilocus
sequence typing (MLST) method (26).
Statistical analysis
All data were analyzed using the SPSS 20.0 software
program forWindows (SPSS Inc., USA). The exact Fisher’s
test and chi-square test were used to compare data.
Significance was established at 5% (P,0.05).
Results
Bacterial isolates
Nasal and skin lesion swabs were collected from 106 AD
patients. Ninety (85%) patients presented S. aureus isolates
in nares, and 8 (7.5%) also presented the pathogen in
their skin infections. Two patients had two infected lesions
positive for S. aureus, for a total of 10 S. aureus isolates
from skin infections. Among 90 patients with S. aureus
isolates, 24 (26.6%) had MRSA. The majority (86.6%) of
patients with S. aureus had moderate or mild SCORAD
values. Only 12 (13.4%) patients had severe SCORAD
values (Table 1).
Antimicrobial susceptibility and MIC
A total of 100 S. aureus isolates (90 from nares and 10
from skin lesions) were evaluated, and 24 were positive
for MRSA. All isolates were susceptible to ciprofloxacin,
chloramphenicol, linezolid, rifampicin, teicoplanin, tigecy-
cline, and trimethoprim/sulfamethoxazole. Antimicrobial
resistance was detected for erythromycin (40%), clinda-
mycin (15%), tetracycline (12%), mupirocin (8%), and
gentamicin (7%) (Table 1).
For oxacillin, 76% of the isolates in both nasal and skin
sites presented MIC values between 0.5 and 1 mg/mL, but
the values ranged from 2 to 64 mg/mL among the MRSA
isolates (Table 1). For vancomycin, the values ranged from
0.5 to 2 mg/mL for all isolates. The eight mupirocin-resistant
S. aureus in atopic dermatitis children 589
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MRSA isolates presented high MIC values for mupirocin
(>1024 mg/mL).
SCCmec typing and PVL genes
Among the 24 MRSA isolates, 23 (95.8%) carried the
SCCmec IV, and 1 isolate was nontypeable and presented
the complex A for the mec gene associated with the ccr 3
(Table 1).
Among 90 patients, 21 (23.3%) carried isolates with the
PVL genes in the nares. Among the 8 patients with S.
aureus isolates in their skin lesions, 6 (75%) possessed
PVL genes. Among the children with moderate and severe
SCORAD scores, 13 (32.5%) of 40 and 4 (33.3%) of 12
presented isolates positive for the PVL genes. Among
patients with mild SCORAD, only 4 (10.5%) of the 38
presented this condition (P=0.0095). From the 100 S.
aureus isolates evaluated, 18 (23.7%) of 76 methicillin-
sensitiveS. aureus (MSSA) and 11 (46%) of 24MRSAwere
positive for the PVL genes.
PFGE and MLST analysis
PFGE analysis showed that for 8 patients with at least
two positive sites for S. aureus, 5 of them had isolates
related to the USA1100/ST30 (3 patients) and USA800/
ST5 (2 patients) lineages (Table 2). Two patients had
isolates related to the USA400/ST1 lineage on skin lesions.
The same lineages of S. aureus were found in the nares
and skin lesions of four patients. All USA1100/ST30 and
USA400/ST1 isolates were PVL positive.
Eight samples did not have profiles related to any
previously described lineage. Among them, two isolates
recovered from skin lesions belonged to ST83 and ST1635.
One nare isolate was included in ST718. Two isolates (nasal
and skin lesion) from the same patient belonged to ST188,
but one of themwasMRSA and the other wasMSSA. A new
sequence type, ST2791 (allelic profile 3-1-1-8-12-1-1) that
differs from ST188 with an alteration in the yqil allele, was
found associated with three isolates recovered from the
same patient.
Discussion
Various studies have characterized S. aureus isolates
from AD patients (8,9,11-13,27,28). In this investigation,
we found a very high prevalence of S. aureus among
the AD patients. Out of 106 patients, 90 (85%) exhibited
nasal colonization by this pathogen. Other studies
have reported a prevalence of nasal carriers of up to
80% among AD children around the world (7-9). Graber et
al. (9) conducted a study in children suffering from
different chronic skin diseases and demonstrated that
patients with AD were the most densely colonized with S.
aureus. This might be related to the supposed role of S.
aureus in the pathogenesis of this disease and/or may be
associated with defective innate immunity in these
patients (29).
Among the 90 patients colonized by S. aureus isolates,
86.6% presented mild or moderate AD (Table 1).
Interestingly, Balma-Mena et al. (12) found that among
200 AD pediatric patients colonized by S. aureus who
attended a dermatological outpatient clinic in Canada, 81%
presented with themild andmoderate forms of AD, which is
very similar to our findings. On the other hand, Pascolini
et al. (13) verified that 77% of Italian children with high
SCORAD values presented with S. aureus colonization,
while only 15% of children had mild AD. Likewise, Rojo
et al. (30) found a high prevalence rate of S. aureus among
patients in Spain with moderate and severe AD. These
conflicting results indicate that both the presence of the
pathogen and its production of virulence factors may be
relevant in AD aggravation.
In our study, MRSA isolates were detected in 26.6% of
patients. However, studies in the literature have reported
MRSA prevalence rates ranging from 0.5% to 16% in AD
pediatric patients (7,9,12,13). The high level found in our
study may be explained, in part, by the climatic character-
istics of our country, the social aspects of the patients
enrolled (largely low income), and the high prevalence of
MRSA (7.5%) in the Brazilian healthy infant population
(31). High methicillin resistance among S. aureus isolates
can be worrying because these patients require aggres-
sive antibiotic therapy and the b-lactam drugs are the first
choice in AD staphylococcal infections. Furthermore, the
high resistance level to mupirocin that was observed in all
mupirocin-resistant MRSA isolates in this study may have
prevented decolonization of these patients.
Among the MRSA isolates, 95.8% carried SCCmec IV.
Likewise, Chung et al. (11) showed the predominance of
SCCmec IVamong isolates frompediatricADpatients inSouth
Korea. However, Lo et al. (32) conducted a study with AD
pediatric patients in Taiwan and identified SCCmec V as the
prevalent cassette. As S. aureus belonging to ST59/SCCmec
V is the most prevalent lineage in the Taiwan community (33),
the lineage characteristics found in AD patients might be
specific for eachgeographical region. This hypothesis could be
supported by the PFGE and MLST analyses results of our
isolates. Among 18 S. aureus isolates evaluated by these
methods, 10 (55.5%) belonged to the USA1100/ST30,
USA400/ST1, and USA800/ST5 lineages that are normally
associated with MRSA isolates in Brazil (16,22). Also,
USA300/ST8 and the isolates from clonal complexes 5, 45,
and 80 are frequently found in both AD patients and healthy
community populations in the USA and Canada (9,28).
In the present study, five PFGE profiles belonging
to ST83, ST188, ST718, ST1635, and ST2791 (a new
sequence type related to ST188) were detected in isolates
from five different patients. Among these lineages, only
ST188 had been previously detected in Brazil among MSSA
isolates recovered from hospitalized patients (22).
Interestingly, ST188 was the most common lineage isolated
from adults and adolescents with AD colonized by S. aureus
in South Korea, accounting for 19.2% of the isolates (27).
S. aureus in atopic dermatitis children 591
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Furthermore, the authors also noted a wide diversity of
lineages including sporadic and unusual clones among
individuals with AD, which is similar to our findings.
Our molecular analysis of nares and skin lesion isolates
recovered from the same patient showed that the isolates
were identical in four of the eight (50%) cases. Other studies
have also shown that the majority of S. aureus isolates
recovered from the nares and skin lesions of the same
pediatric AD patient exhibited the same genotypic profiles
(9,13).
S. aureus is known to produce various potent toxins
that can aggravate AD by triggering skin inflammation, and
PVL is believed to play a key role in this recrudescence (6).
In this study, PVL genes were detected in 29 isolates from
21 (23.3%) patients and were found in 75% of skin lesions.
These findings differ from themajority of studies conducted
in other countries that have found very low PVL rates
ranging from 0% to 4.2% (11,13,28). However, Lo et al.
(32) found that 71% of MRSA isolates recovered from skin
lesions and nares of AD children in Taiwan were PVL
positive. These authors detected isolates mainly belonging
to ST59, a lineage strongly associated with PVL genes in
that country, justifying its presence in AD patients (33). In
the present study, all USA1100/ST30 isolates, a PVL-
producing lineage prevalent in Rio de Janeiro (16), were
positive for PVL genes. Furthermore, USA400/ST1 isolates
were also positive for these genes, an unusual character-
istic among isolates of this lineage in Brazil. Moreover,
three isolates of a new lineage (ST2791) related to ST188
were also detected, and all of them were positive for PVL
genes. This might be associated with the high occurrence
of PVL-positive isolates recovered in this study.
Interestingly, we found that PVL genes were signifi-
cantly more prevalent among children with moderate and
severe SCORAD values (P=0.0095) compared to those
with mild SCORAD values. Yeung et al. (28) evaluated 119
nasal and skin S. aureus isolates from adults and children
with AD in Canada and did not find any obvious association
between these genes and increased disease severity.
Although further studies are necessary to elucidate the role
of PVL in AD recrudescence, our data suggest that PVL
might contribute to the greater severity of this skin disease
among the children in this study.
Our results increase the understanding of MRSA
epidemiology in AD patients and can help clinicians to
design improved therapies. Children colonized by MRSA
underwent decolonization with topical mupirocin, except for
those carrying mupirocin-resistant isolates, which were
treated with trimethoprim/sulfamethoxazole (data not
shown). Some authors have shown that community-
acquired MRSA isolates are susceptible to trimethoprim/
sulfamethoxazole (34) and have suggested the use of this
drug as an option in MRSA decolonization schemes (35,36).
These data are in agreement with our study showing that
all MRSA isolates were trimethoprim/sulfamethoxazole-
susceptible. Thus, patients with cutaneous MSSA and
MRSA infections were successfully treated with cefalexin
and trimethoprim/sulfamethoxazole, respectively.
This study showed a high prevalence of S. aureus
and MRSA recovered from pediatric patients with AD in
Brazil, including emergent lineages. We also found a high
frequency of PVL genes among severe and moderate
SCORADpatients. These factorsmay affect lesion severity
and thus may contribute to improvements in the manage-
ment policies of pediatric AD patients.
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